Yahoo
    • Mail
    • ALL ORDS7,290.70+0.24%
    • AUD/USD0.6504-0.02%
    • ASX 2007,110.80+0.27%
    • OIL68.15+0.09%
    • GOLD1,973.90-0.41%
    • Bitcoin AUD41,444.14-0.66%
    • CMC Crypto 200599.83-2.32%
    Explore/

    Most active penny stocks

    Most active penny stocks

    56.33k followers • 31 symbols Watchlist by Yahoo Finance

    Follow this list to discover and track penny stocks with the highest daily volume.

    31 symbols

    • CHFLF0.570.02%

      China Feihe Limited

    • BRFS1.640.15%

      BRF S.A.

    • OPEN2.640.18%

      Opendoor Technologies Inc.

    • MVIS4.690.23%

      MicroVision, Inc.

    • SHCR1.490.05%

      Sharecare, Inc.

    • DPLS0.010.00%

      DarkPulse, Inc.

    • VTGN0.140.01%

      VistaGen Therapeutics, Inc.

    • PHIL0.000.00%

      Philux Global Group Inc.

    • WLGS1.700.31%

      WANG & LEE GROUP, Inc.

    • IDAI2.540.49%

      T Stamp Inc.

    • AIAD0.010.00%

      AiAdvertising, Inc.

    • MRKR1.780.46%

      Marker Therapeutics, Inc.

    • ARDS0.400.21%

      Aridis Pharmaceuticals, Inc.

    • VQS0.300.07%

      VIQ Solutions Inc.

    • TSOI0.000.00%

      Therapeutic Solutions International, Inc.

    • TENX0.360.04%

      Tenax Therapeutics, Inc.

    • NSAV0.000.00%

      Net Savings Link, Inc.

    • BJDX0.240.04%

      Bluejay Diagnostics, Inc.

    • EEGI0.000.00%

      Eline Entertainment Group, Inc.

    • MCOA0.000.00%

      Marijuana Company of America, Inc.

    • SYSX0.000.00%

      Sysorex, Inc.

    • GMZP0.000.00%

      GEMZ Corporation

    • VBHI0.000.00%

      Verde Bio Holdings, Inc.

    • EPAZ0.010.00%

      Epazz, Inc.

    • SEII0.000.00%

      Sharing Economy International Inc.

    • WTII0.000.00%

      Water Technologies International, Inc.

    • VTXB0.000.00%

      Vortex Brands Co.

    • AAPJ0.000.00%

      AAP, Inc.

    • SFLM0.000.00%

      SFLMaven Corp.

    • FUNR0.000.00%

      FUNR

    • Investing.com

      Asia FX inches higher on bets of Fed pause, debt ceiling progress

      Investing.com -- Most Asian currencies advanced on Thursday, while the dollar inched lower tracking comments from Federal Reserve officials touting a potential pause in the rate hike cycle in June.

    • GlobeNewswire

      Tenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Use of Oral Levosimendan (TNX-103) in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

      Once granted, this patent will provide intellectual property protection until December 2040, and may qualify for additional U.S. patent term extension beyond 2040 There are currently no FDA approved treatments for PH-HFpEF, a condition affecting more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030Once granted, this patent will significantly broaden Tenax’s U.S. intellectual property (IP) protection for a market with the potential to

    • FX Empire

      AUDUSD Forecast – Aussie Dollar Continues to Show Weakness

      The Aussie dollar initially tried to rally during the trading session on Wednesday but gave back gains as we continue to see a lot of negativity out there.

    • GlobeNewswire

      Trust Stamp Announces Notice of Allowance for New U.S. Patent Related to Identity Authentication Via the Control of Third-Party Accounts

      Atlanta, May 31, 2023 (GLOBE NEWSWIRE) -- Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity Company™ providing AI-powered trust and identity services used globally across multiple sectors, announced that it has received a Notice of Allowance for an additional patent by the United States Patent and Trademark Office. This Notice of Allowance follows an previous patent allowance announced earlier this month. The patent titled, “Systems and Methods for Identity Verification via Third-Party Acco

    • PR Newswire

      Vortex Brands Initiates Hiring Process for Programmers to Develop AI-Based Bot for Bitcoin Trading

      Vortex Brands Co. (OTC: VTXB), a publicly traded company specializing in cryptocurrency solutions, is pleased to announce the commencement of its hiring process to assemble a team of skilled programmers. The objective is to build an advanced AI-based bot specifically designed for bitcoin trading.

    • GlobeNewswire

      Aridis Receives Agreement from the FDA on a Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design

      LOS GATOS, Calif., May 31, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced positive feedback from the FDA on the Company’s proposed single confirmatory Phase 3 study of investigational monoclonal antibody candidate AR-301, which is being developed as an adjunctive therapy in combination with standard of care (SOC) antibiotics for the treatment of pneumonia caused by Gram-positive bacteria Staphylococcus aureus (S. aureus) in mechanically ventilated hospitaliz

    • GlobeNewswire

      Sharecare concludes strategic review, announces share repurchase program

      Board of Directors re-authorizes $50 million for stock repurchases; determines alignment, optimization, and growth initiatives best path to maximize value for shareholdersATLANTA, May 31, 2023 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced that its Board of Directors has completed the strategic review process initiated in August 2022. After evaluating a number of alternatives with the support of adv

    • Zacks Small Cap Research

      BJDX: Orchestrating a New Testing Standard

      By John Vandermosten, CFA NASDAQ:BJDX READ THE FULL BJDX RESEARCH REPORT INITIATING COVERAGE We are initiating coverage of Bluejay Diagnostics, Inc. (NASDAQ:BJDX) assigning a valuation of $2.00 per share. Bluejay is a diagnostic device development company offering its Symphony product pipeline. The company is advancing a sepsis triage and monitoring system for intensive care unit (ICU), emergency

    • GlobeNewswire

      Marker Therapeutics Reports Pre-Clinical Data of its MT-601 MultiTAA-Specific T Cell Product Candidate in Lymphoma Cells

      MT-601 showed anti-tumor activity against CD19 CAR T refractory lymphoma cells in vitroHOUSTON, May 31, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced pre-clinical data from the Company’s multiple tumor-associated antigens (multiTAA)-specific T cell product candidate MT-601 in

    • Investing.com

      Asia FX dips, yuan hits 6-mth low as Chinese economic rebound slows

      Investing.com -- Most Asian currencies fell on Wednesday, with the Chinese yuan trading at a six-month low on more signs of a slowing economic recovery in the country, while the dollar firmed ahead of a vote to raise the U.S. debt ceiling.

    • Investing.com

      Australia CPI inflation beats expectations in April, feeds RBA hawks

      Investing.com -- Australian consumer price index inflation rose more than expected in April amid stubbornly high fuel and housing prices, likely inviting more interest rate hikes by the Reserve Bank in the coming months.

    • Business Wire

      Vistagen to Present Fasedienol (PH94B) Safety and Exploratory Efficacy Data from Phase 3 Open-Label Social Anxiety Disorder Study at American Society for Clinical Psychopharmacology Annual Meeting

      SOUTH SAN FRANCISCO, Calif., May 30, 2023--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced that safety and exploratory efficacy data from its Phase 3 open-label study of fasedienol (PH94B) nasal spray for the treatment of adults with social anxiety disorder (SAD) will be presented in a late-breaking poster presentat

    • FX Empire

      AUDUSD Forecast – Australian Dollar Initially Pulls Back but Finds Legs

      The Aussie dollar has initially fallen during the trading session on Tuesday but turned around to find plenty of support later in the day.

    • FX Empire

      AUDUSD Forecast – Australian Dollar Rallies on Monday

      The Australian dollar rallied rather significantly during the trading session on Monday, although it was Memorial Day, so that’s something worth paying attention to.

    • Investing.com

      Asia FX muted, dollar steady as Fed fears stifle debt deal cheer

      Investing.com -- Most Asian currencies kept to a tight range on Monday, while the dollar steadied at a two-month high as signs of sticky inflation and rising U.S. interest rates largely offset optimism over a U.S. debt ceiling deal.

    • GlobeNewswire

      PHI Group, Inc (n/k/a Philux Global Group Inc.) Joins Vietnam-base SSE Group JSC to Provide Solutions to Global Green House Gas Emissions with SSE Group’s Proprietary Technologies.

      New York, May 26, 2023 (GLOBE NEWSWIRE) -- PHI Group, Inc. (n/k/a Philux Global Group Inc., www.phiglobal.com, PHIL), is pleased to announce that the Company has signed a Business Cooperation Agreement with SSE Group JSC, a Vietnamese joint stock company, to jointly cooperate in the areas of energy efficiency and mitigation of global greenhouse gas (GHG) emissions by using SSE Group’s proprietary technologies. According to the agreement, SSE Group JSC and Philux Global Group Inc. have incorporat

    • FX Empire

      AUD/USD Weekly Forecast – Australian Dollar Gets Hammered for the Week

      The Aussie dollar has broken down significantly during the trading week, as the 0.6 6 Level Has Given Way.

    • FX Empire

      AUDUSD Forecast – Australian Dollar Bounces Into the Weekend

      The Aussie dollar bounced a bit early on Friday to show signs of life again as we head into the weekend.

    • Investing.com

      Australian retail sales flat in April as consumers tighten purse strings

      Investing.com-- Australian retail sales missed expectations in April, remaining flat from the prior month as a rising cost of living and high interest rates saw consumers pulling back further on spending big.

    • GlobeNewswire

      Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-Q

      LOS GATOS, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on May 23, 2023 indicating that the Company is not currently in compliance with Nasdaq’s Listing Rules (the “Listing Rules”) due to the Company’s inability to timely file its Form 10-Q for the three month

    • GlobeNewswire

      Opendoor Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      SAN FRANCISCO, May 25, 2023 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (“Opendoor”) (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today announced that on May 23, 2023, the Compensation Committee of Opendoor’s Board of Directors granted restricted stock units covering 5,073,831 shares of its common stock to thirty-three (33) non-executive employees, in connection with their commencement of employment, under the Opendoor Technologies Inc. 2022 Induceme

    • Business Wire

      Therapeutic Solutions International Launches Subsidiary Company to Commercialize Clinical Data and IND for Treatment of Chronic Traumatic Encephalopathy (CTE) with JadiCell Universal Adult Stem Cells

      ELK CITY, Idaho, May 25, 2023--Therapeutic Solutions International (TSOI) announced the creation of CTE Biologics, Inc. as a subsidiary company dedicated to commercializing the JadiCell adult stem cell platform for treatment of chronic traumatic encephalopathy.

    • FX Empire

      AUDUSD Forecast – Australian Dollar Continues to Look Threatened

      The Aussie dollar had sold off rather drastically and Wednesday, and Thursday it looks like we are seeing more of the same.

    • Investing.com

      Dollar in demand after Fitch signals possible U.S. rating downgrade

      The U.S. dollar gained in Europe Thursday, climbing to a two-month high on rising fears of a U.S. default as Fitch threatens a rating downgrade. At 02:55 ET (06:55 GMT), the Dollar Index, which tracks the greenback against a basket of six other currencies, rose 0.2% to 103.955, just below the 104.05 overnight peak, the highest level since mid-March. The dollar’s safe haven status has meant that it has benefited from the lack of progress in the talks to lift the U.S. government's $31.4 trillion debt ceiling, with the early-June deadline that Treasury Secretary Janet Yellen said is when it’s “highly likely” that her department will run out of money drawing nearer.

    • Investing.com

      Asia FX weakens amid debt ceiling woes, dollar at two-month high

      Investing.com -- Most Asian currencies slid on Thursday, while the dollar hit a two-month high as uncertainty over raising the U.S. debt limit and averting a default saw investors avoid risk-driven assets.

    Finance
    • Watchlists
    • My Portfolios
    • Markets
    • Money
    • Work
    • Technology
    • Industries
    • The New Investors
    • All Markets Summit
    • Give Feedback